EventsMOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Event submissions
Published
with-doi10.3390/mol2net-08-12448
This submission belongs to the session 02. CHEMBIO.ORG-08: Org. Chem., Med. Chem., Mol. Biol., & Pharm. Industry Congress, Paris, France-Galveston, USA, 2022. of the event MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published date
23 Mar, 2022
Academic Editor
author-avatarHumbert G. Díaz
Citation
Luisa Chocarro, Ester Blanco, Hugo Arasanz, Leticia Fernández Rubio, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro, Grazyna Kochan, David Escors, LAG-3 Role in Cardiovascular Diseases, in Proceedings of MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed., 1 January–15 January 2023, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-08-12448
Share
Email
FaceBook
Twitter
Linkedin

LAG-3 Role in Cardiovascular Diseases

Luisa Chocarro 1
Ester Blanco 1,2
Hugo Arasanz 1,3
Leticia Fernández Rubio 1
Miriam Echaide 1
Maider Garnica 1
Pablo Ramos 1
Sergio Piñeiro 1
Grazyna Kochan 1
David Escors 1
1. OncoImmunology Unit, Navarrabiomed-Fundacion Miguel Servet, Universidad Pública de Navarra (UPNA), Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Navarra, Spain
2. Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain
3. Medical Oncology Unit, Hospital Universitario de Navarra (HUN), Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Navarra, Spain
Abstract
Keywords
LAG-3
Cardiovascular Diseases
Coronary Heart Disease
Myocardial Infarction